MedTrace Logo

Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies

NCT01163526 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2017-01-30

No results posted yet for this study

Summary

A research study of liver perfusion (how blood flows to the liver over time). We hope to learn whether perfusion characteristics of liver masses may be predictive of response to treatment and whether liver perfusion characteristics can be used to follow response to treatment.

Conditions

Interventions

PROCEDURE

CT perfusion

Sponsors & Collaborators

  • Siemens Corporation, Corporate Technology

    collaborator INDUSTRY

  • GE Healthcare

    collaborator INDUSTRY

  • Stanford University

    lead OTHER

Principal Investigators

  • Aya Kamaya · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01163526 on ClinicalTrials.gov